ABSI
Absci Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -2.6% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 36.37K | $325,139 | n/a | n/a |
| Q2 2026 | 82 | +7 | 112.04M | $1.30B | +11 | −4 |
| Q1 2026 | 77 | +13 | 90.86M | $272.61M | +16 | −3 |
| Q4 2025 | 64 | 0 | 89.20M | $311.30M | n/a | n/a |
| Q3 2025 | 15 | -1 | 60.11M | $182.75M | +1 | −2 |
| Q2 2025 | 13 | 0 | 50.18M | $128.95M | +2 | −2 |
| Q1 2025 | 10 | 0 | 17.56M | $44.09M | +1 | −1 |
| Q4 2024 | 10 | 0 | 15.09M | $39.55M | +1 | −1 |
| Q3 2024 | 9 | 0 | 11.86M | $45.29M | +1 | −1 |
| Q2 2024 | 9 | n/a | 12.14M | $37.33M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 19.13M | n/a | $49.17M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 2 | ARK Investment Management ✦ | 10.05M | -8.3% | $25.82M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 8.36M | n/a | $21.49M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 4 | The Vanguard Group ✦ (passief) | 6.45M | n/a | $16.58M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 5 | Geode Capital Management ✦ (passief) | 2.45M | +22.5% | $6.29M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passief) | 1.80M | +8.0% | $4.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 612.88K | Nieuw | $1.58M | 0.0% | New | 1 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 580.44K | +28.7% | $1.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 378.26K | +17.1% | $972,130 | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 10 | Millennium Management ✦ | 229.96K | -78.6% | $590,995 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 60.64K | +9.2% | $155,850 | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 12 | T. Rowe Price ✦ | 54.70K | +56.3% | $141,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 17.91K | Nieuw | $46,024 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Marshall Wace | $1.58M | 0.0% |
| D. E. Shaw & Co. | $46,024 | 0.0% |
Verlaten
| Citadel Advisors | $2.39M | was 0.0% |
| Point72 Asset Management | $120,832 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 159 houders, 118.34M aandelen, $354.64M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.